Psychiatry
Medicines

Psychiatry Medicine Supply for Hospitals & International Buyers

Psychiatric and mental health conditions represent one of the largest contributors to global disease burden, with the World Health Organization estimating that depression alone affects over 280 million people worldwide. Schizophrenia affects around 24 million people globally, while bipolar disorder affects approximately 40 million. In GCC countries and across Africa, psychiatric services have expanded significantly in recent years, with major investments in dedicated mental health hospitals and outpatient psychiatry units. These facilities require reliable access to a broad range of psychotropic medicines, and Euro Biom supplies these from UK-licensed sources to hospitals and distributors across the region.

Antipsychotic medicines form a cornerstone of our psychiatry portfolio. We supply first-generation (typical) antipsychotics including haloperidol, chlorpromazine, trifluoperazine, flupentixol and zuclopenthixol in both oral and injectable forms. For second-generation (atypical) antipsychotics, our range covers olanzapine, quetiapine, risperidone, aripiprazole, amisulpride and paliperidone. Clozapine, used for treatment-resistant schizophrenia, is available along with the associated blood monitoring kits required for clozapine titration protocols. Many psychiatric hospitals in GCC countries and Africa run structured clozapine monitoring programmes and require a consistent supply partner who understands the logistics involved.

Depot and long-acting injectable (LAI) antipsychotics are essential for patients with adherence challenges or who require sustained plasma levels between clinic visits. We supply zuclopenthixol decanoate, flupentixol decanoate, haloperidol decanoate and fluphenazine decanoate from the first-generation range. From the second-generation LAI range, we can source risperidone microspheres (Risperdal Consta), paliperidone palmitate (Xeplion and Trevicta) and aripiprazole prolonged-release injectable. These depot formulations are in regular demand from psychiatric hospitals in Saudi Arabia, the UAE, Qatar and across Sub-Saharan Africa, where outpatient compliance monitoring is a clinical priority.

Antidepressants, Mood Stabilisers and Anxiolytics

Antidepressant medicines cover a wide range of drug classes, each with specific clinical indications and tolerability profiles. Our SSRI range includes sertraline, fluoxetine, escitalopram, citalopram and paroxetine. SNRIs available include venlafaxine and duloxetine, the latter also indicated for generalised anxiety disorder and diabetic neuropathic pain. Mirtazapine, an atypical antidepressant with additional sedative properties, is widely used in hospital inpatient settings. Tricyclic antidepressants including amitriptyline, clomipramine and nortriptyline remain important in certain clinical contexts and are available through our sourcing network. Agomelatine and bupropion are also within our supply capability.

Mood stabilisers are critical for managing bipolar disorder and require careful therapeutic monitoring. Lithium carbonate and lithium citrate are available in standard and modified-release formulations. Sodium valproate and valproic acid are used as mood stabilisers as well as for epilepsy, and we supply these in the tablet, liquid and intravenous forms. Lamotrigine is a key agent for bipolar depression and is available across multiple strengths. Carbamazepine is used in some bipolar protocols as well as for trigeminal neuralgia. For hospitals in countries where lithium serum level monitoring infrastructure exists, we can supply the full clinical package including lithium preparations and documentation supporting safe use.

Anxiolytics and hypnotic medicines are required across inpatient psychiatric units, emergency departments and outpatient clinics. Benzodiazepines we can supply include diazepam, lorazepam, clonazepam, temazepam and nitrazepam. Non-benzodiazepine hypnotics including zopiclone and zolpidem are available. Buspirone is available for generalised anxiety disorder as a non-sedating option. These are controlled medicines in most jurisdictions, and Euro Biom advises all buyers on the import licence and controlled drug permit requirements applicable in their destination country prior to shipment. We work closely with buyers to ensure all documentation is in place before goods are despatched.

Psychiatric hospitals across GCC countries frequently request specific UK-branded versions of psychotropic medicines, citing consistency of response and patient familiarity with particular tablet sizes and formulations. Supply disruptions in local markets, combined with the difficulty of sourcing some specialist products, make UK wholesale export supply an important channel for these institutions. Euro Biom holds MHRA Wholesale Dealer Authorisation and is GDP compliant, providing the regulatory documentation required by hospital procurement departments and national medicines authorities in the UAE, Saudi Arabia, Qatar, Kuwait, Bahrain and Oman. We also supply to NGO programmes, prison health services and private psychiatric facilities across Africa.

Euro Biom offers both standard and urgent supply of psychiatry medicines, with a sourcing network covering all major UK-licensed manufacturers and wholesalers. Our team can respond quickly to shortages and can source named patient and unlicensed psychiatric medicines where a clinical need is demonstrated. All shipments are GDP compliant, with full temperature monitoring for medicines requiring controlled storage conditions. Submit your product list and destination to our enquiries team, and we will confirm availability, pricing and lead times promptly.